What's Happening at Biova

Biova® LLC

Olathe, KS, USA (March 6, 2016) — Interested in what drives Biova to produce the best water soluble egg membrane ingredient on the market? A new video at Biova.com shows how this company is forging forward to make a difference in the natural products industry.
 
“Video offers an insightful, impactful way to tell our story,” said Matt Stegenga, Biova president. “Egg membrane is a new product category, so it’s important to capture how our forward thinking, patented technology, our operations, and our talented people have combined to make these market-leading ingredients.”
 
The short video showcases Biova's people and operations, both in the manufacturing facilities and labs of Johnston, Iowa, as well as the sales and marketing offices in the Kansas Biosciences Authority in Olathe, Kan. 
 
Key Biova personnel are introduced and lead viewers through the steps taken each day to fulfill Biova’s mission of creating quality ingredients, with uniform profiles for manufacturers around the world. 
 
“Our ingredients offer multiple delivery systems for multiple market applications across a variety of products,” said Stegenga. “It’s important that our message goes out in a variety of ways as well.”

Johnston, Iowa, USA (22 Sept. 15)BiovaFlex®, a water soluble egg membrane (WSEM) ingredient, was associated with improved joint function, increased comfort in daily activities, and elevated physical activity according to a just-published, peer-reviewed research study article. Specific results could be seen in as few as five days.

BiovaFlex is manufactured in the United States by Biova LLC.

The article, "Support of Joint Function, Range of Motion, and Physical Activity Levels by Consumption of a Water-Soluble Egg Membrane Hydrolyzate" in the September issue of Journal of Medicinal Food, is based on research conducted by NIS Labs, Klamath Falls, Ore., USA. The randomized, double-blind, placebo-controlled crossover study showed consuming 450mg of BiovaFlex daily was associated with improved joint Range of Motion (ROM) in multiple  areas including the neck, back, hips, shoulders and knees. Increased physical energy and activity levels were observed.  Subgroup analysis showed reduction of back pain after just five days.

“Research demonstrating quantitative ROM and pain improvements is significant, but the real takeaway is that people feel better when taking BiovaFlex,” said Matt Stegenga, Biova president. “Exercise, every day life, can cause discomfort. The ability to do the daily activities one wants or needs to accomplish is what people value. Showing rapid improvement in back pain after just five days is exceptional in the current natural ingredients marketplace.”

The research also highlighted the importance of a study population with no diagnosis of joint diseases; meaning the improvements were broad, and independent of a person’s identified chronic joint and mobility problems. The article concluded that, with more research, WSEM may hold further promise as a natural support for maintaining quality of life in older populations, athletes and patients recovering from joint and muscle injuries. The complete article can be found at: http://biova.com/research

“Our R&D is always researching technology and partnering on trials,” said Stegenga. “While we don’t always choose to publish findings, we’ve long known from clinical trial data that BiovaFlex holds special benefits. We’re excited to share this study with the public—especially given the substantial marketing support it provides our customers.”

About Biova:
Privately held and globally distributed, Biova is the market leader for water soluble egg membrane (WSEM) ingredients offering proven health benefits: BiovaFlex® for joint health; BiovaDerm® for skin care; and BiovaPlex® for animal health. Biova's patented water soluble process creates expanded delivery options for consumer products, including functional foods, beverages, lotions and more. Years of dedicated investment, ongoing scientific research and leading-edge technology are at the core of these all-natural, ultra pure, nutrient-rich ingredients. A focus on sustainable production, anchored by vertical integration with some of the largest US-domestic egg producing and processing partners, assures Biova unmatched raw material supply—the right combination of access and capability to drive opportunity and growth worldwide.

 

Johnston, Iowa USA (December 16, 2014) — Biova LLC, the global leader in water soluble egg membrane (WSEM), announces new executive leadership:

Matt Stegenga, current director of marketing for Biova, has been named president. He succeeds Dennis Casey, PhD, who will continue as part of Biova’s board of directors. “With more than 10 years experience working with egg membrane, nobody knows this technology and the market better than Matt,” said Casey. Stegenga will continue Biova’s global market development, focusing on expanding applications for Biova’s patented technologies and branded ingredients.

Biova also introduces Craig Rowles, DVM, who joins Biova in January as chief operating officer overseeing multiple operations in Iowa and Kansas. With 30 years of experience, Rowles will also direct Biova’s special research and development initiatives, aimed at expanding market applications for Hydro5™, OvaPure™, Ovacore™ and other nascent technologies. 

“These are exciting times for Biova. We’ve experienced significant growth in recent years—we have global customers to serve, multiple research studies engaged, five facilities and offices to manage, and ever-expanding market opportunities,” said Stegenga. “People drive business, and having the right people in the right places is key to our success. Biova’s well positioned for the future.”

Page 2 of 6

  • Visit with Biova at: 

     

    March 10-12, 2017 :
    EXPO West/Engredea—Booth #566
    Anaheim Convention Center
    Anaheim, CA, USA

     

    May 9-11, 2017 : Vitafoods—Booth #D53
    Palexpo, Geneva, Switzerland